- Home
- BPMC vs ACA Comparison
BPMC vs ACA Comparison
Compare BPMC & ACA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- ACA
- Stock Information
- Founded
- BPMC 2008
- ACA 2018
- Country
- BPMC United States
- ACA United States
- Employees
- BPMC N/A
- ACA N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- ACA Metal Fabrications
- Sector
- BPMC Health Care
- ACA Industrials
- Exchange
- BPMC Nasdaq
- ACA Nasdaq
- Market Cap
- BPMC 5.8B
- ACA 4.8B
- IPO Year
- BPMC 2015
- ACA N/A
- Fundamental
- Price
- BPMC $99.18
- ACA $86.29
- Analyst Decision
- BPMC Buy
- ACA Strong Buy
- Analyst Count
- BPMC 21
- ACA 4
- Target Price
- BPMC $124.05
- ACA $105.50
- AVG Volume (30 Days)
- BPMC 1.0M
- ACA 278.5K
- Earning Date
- BPMC 05-01-2025
- ACA 05-06-2025
- Dividend Yield
- BPMC N/A
- ACA 0.23%
- EPS Growth
- BPMC N/A
- ACA N/A
- EPS
- BPMC N/A
- ACA 1.59
- Revenue
- BPMC $562,121,000.00
- ACA $2,603,300,000.00
- Revenue This Year
- BPMC $44.85
- ACA $13.58
- Revenue Next Year
- BPMC $32.06
- ACA $6.58
- P/E Ratio
- BPMC N/A
- ACA $54.60
- Revenue Growth
- BPMC 99.19
- ACA 10.44
- 52 Week Low
- BPMC $73.04
- ACA $68.11
- 52 Week High
- BPMC $121.90
- ACA $113.43
- Technical
- Relative Strength Index (RSI)
- BPMC 65.95
- ACA 62.43
- Support Level
- BPMC $97.91
- ACA $81.59
- Resistance Level
- BPMC $104.86
- ACA $88.20
- Average True Range (ATR)
- BPMC 3.74
- ACA 2.62
- MACD
- BPMC 1.50
- ACA 1.01
- Stochastic Oscillator
- BPMC 83.26
- ACA 90.68
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About ACA Arcosa Inc.
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.